MeiraGTx Holdings (MGTX) Assets Average (2018 - 2025)
MeiraGTx Holdings posted quarterly Assets Average of $217.0 million for Q4 2025, down 23.78% year-on-year from $284.6 million in Q4 2024, and up 11.78% on a QoQ basis from $194.1 million in Q3 2025.
MeiraGTx Holdings (MGTX) has 8 years of Assets Average data on file, last reported at $217.0 million in Q4 2025.
- For the quarter ending Q4 2025, Assets Average fell 23.78% year-over-year to $217.0 million; the trailing twelve-month figure through Dec 2025 stood at $217.0 million (down 23.78% YoY), and the FY2025 full-year result was $257.1 million, down 13.8% from the prior year.
- Assets Average for Q4 2025 stood at $217.0 million, up from $194.1 million in the prior quarter.
- Across five years, Assets Average topped out at $351.7 million in Q1 2021 and bottomed at $194.1 million in Q3 2025.
- The 5-year median for Assets Average is $292.8 million (2023), against an average of $285.2 million.
- The widest annual swing landed in 2021, when Assets Average rose 11.95%; it then slumped 31.43% in 2025.
- A 5-year view of Assets Average shows it stood at $311.8 million in 2021, then slipped by 0.62% to $309.8 million in 2022, then slipped by 4.15% to $297.0 million in 2023, then retreated by 4.16% to $284.6 million in 2024, then dropped by 23.78% to $217.0 million in 2025.
- The last three Assets Average figures came in at $217.0 million (Q4 2025), $194.1 million (Q3 2025), and $211.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 5.05 Bn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 216.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 216.95 Mn |
| Sep 30, 2025 | 194.09 Mn |
| Jun 30, 2025 | 211.37 Mn |
| Mar 31, 2025 | 246.88 Mn |
| Dec 31, 2024 | 284.62 Mn |
| Sep 30, 2024 | 283.07 Mn |
| Jun 30, 2024 | 287.94 Mn |
| Mar 31, 2024 | 317.99 Mn |
| Dec 31, 2023 | 296.97 Mn |
| Sep 30, 2023 | 288.73 Mn |
| Jun 30, 2023 | 299.20 Mn |
| Mar 31, 2023 | 303.19 Mn |
| Dec 31, 2022 | 309.82 Mn |
| Sep 30, 2022 | 276.94 Mn |
| Jun 30, 2022 | 270.08 Mn |
| Mar 31, 2022 | 303.93 Mn |
| Dec 31, 2021 | 311.75 Mn |
| Sep 30, 2021 | 315.05 Mn |
| Jun 30, 2021 | 333.22 Mn |
| Mar 31, 2021 | 351.69 Mn |
| Dec 31, 2020 | 328.37 Mn |
| Sep 30, 2020 | 291.83 Mn |
| Jun 30, 2020 | 297.64 Mn |
| Mar 31, 2020 | 314.28 Mn |
| Dec 31, 2019 | 320.82 Mn |
| Sep 30, 2019 | 285.41 Mn |
| Jun 30, 2019 | 255.47 Mn |
| Mar 31, 2019 | 177.37 Mn |
| Dec 31, 2018 | 101.07 Mn |
| Sep 30, 2018 | 111.46 Mn |